Arba Asseris Kotedžas idogen spotlight pakartojimas Puiku Vadovas
Trading Direkt analyserar bolagen på Spotlight 2018-10-18: Plejd & Idogen - YouTube
biotech | pharma | diagnostics | devices
niklas wallett - Idogen
PRESS RELEASE IDOGEN AB
Idogen will be listed on Nasdaq First North Growth Market on June 4, 2020
Idogen files patent application for new tolerogenic cell therapy
Nyemission: Idogen förbereder för fas I/IIa-studie Idogen är ett svenskt bioteknikbolag baserat i Lund. Bolaget utvecklar tolerogena cellterapier som gör det möjligt att undvika en oönskad aktivering av kroppens immunsystem. Cellterapin baseras
Idogen AB | Aktiespararna
Noteringar i veckan
Iodogen | C16H10Cl4N4O2 | ChemSpider
Idogen AB (publ)
Investors Home
Idogen presentation - Idogen
Idogen AB | Aktiespararna
Idogen's Historical Milestones - Idogen
Idogen - Crunchbase Company Profile & Funding
Board and Advisors | Ambulero
Redeye-intervju med Idogens VD om emissionsutfallet och rekryteringen av ny CMO - IPO.se
biotech | pharma | diagnostics | devices
Q3 ENG - Idogen
Idogen Year end report 3 - Idogen
Idogen's cell technology successfully advanced to large-scale production
Idogen - Engineering Immune Tolerance
Idogen AB (publ) Org nr
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community